Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

The unrivalled speaker line-up for 2018

Keynotes

Jim Robinson

Jim Robinson

President US, Astellas

Read more

More information coming soon...

Fabrice Chouraqui

Fabrice Chouraqui

President US, Novartis

Read more

Fabrice Chouraqui is currently working as President of Novartis Pharmaceuticals Corporation.

Fabrice has 20 years of experience in the Pharmaceutical industry, having worked in Research & Development, Commercial and General Management positions in Europe, North America, Asia and Latin America. Prior to joining Novartis in 2010, Fabrice worked for Bristol-Myers Squibb and Hoechst Marion Roussel.

Fabrice holds a Master in Science and a Doctorate in Pharmacy from the University of Paris as well as an MBA degree from INSEAD.

Paul Navarre

Paul Navarre

CEO, Ferring Holding

Read more

Paul Navarre is the Chief Executive Officer of Ferring Holding Inc., the U.S. subsidiary of Ferring Pharmaceuticals (The Ferring Group). Ferring Holding Inc. has more than 800 employees and turnover of over $700M.

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. Ferring identifies, develops and markets innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology, women’s health and orthopaedics.

An accomplished senior executive, Mr. Navarre has built a track record of success spanning 25 years including experience in fast-moving consumer goods and pharmaceuticals. He has served in key strategic positions responsible for operations in Europe, Asia, Africa, Middle East and the U.S. A French national, he has lived and worked in France, Italy, the UK, Switzerland and the U.S.A.

Before joining Ferring, Mr. Navarre was President of International Operations for Allergan. He began his career at Procter and Gamble where over 15 years he held multiple leadership positions in the company’s consumer goods and pharmaceuticals divisions.

Mr. Navarre has solid track record of delivering top line growth in the specialty pharmaceutical business through commercial innovation and customer centric approaches. He is recognized as an authentic visionary leader with the ability to attract and manage multi-functional talents.

Mr. Navarre and his wife have been married for 23 years. They have 4 children and live in New York.

Dr. Carsten Brunn

Dr. Carsten Brunn

Head of Pharmaceuticals, Americas Region, Bayer

Read more

Dr. Brunn was appointed in January 2017 to lead Bayer’s Pharmaceuticals business in the United States, Canada, and Latin America and is an executive member of the Country Council.

Over the last 25 years, he has held a number of senior leadership positions in Europe, Asia and the United States at leading companies such as Eli Lilly, Novartis and Bausch and Lomb. Most recently, he was Head of Bayer Pharmaceuticals Commercial Operations in Japan where he achieved double-digit growth that led to Bayer being recognized as one of the top 10 pharmaceutical companies in Japan for the first time in 26 years. He also served as the Chairman of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan, an organization representing 24 R&D based innovative pharmaceutical companies in Japan. Dr. Brunn joined Bayer Pharmaceuticals in China in 2011 to lead the Global Primary Care business.

Dr. Brunn started his career at Eli Lilly and Company, where he held a variety of managerial positions in sales and marketing in the United States. He is passionate about meeting the needs of customers and patients and has a proven track record for building the right internal culture to drive business growth.

Dr. Brunn graduated from the University of Freiburg in Germany with a Master of Science in Pharmaceutical Science. In addition, he studied at the University of Washington under a research scholarship. He received his PhD in Chemistry from the University of Hamburg, Germany and completed his executive education at London Business School.

Born in Tuebingen, Germany, Dr. Carsten Brunn is married with one son and resides in New Jersey.

Sue Mahony

Sue Mahony

SVP & President, Lilly Oncology

Read more

Sue Mahony, Ph.D., became president of Lilly Oncology in March 2011. She is also a senior vice president for Eli Lilly and Company and a member of the company’s executive committee.

In May 2009, she was appointed senior vice president, human resources and diversity for Lilly. Previously, she led Lilly’s operations in Canada.

Mahony was born and educated in the United Kingdom, where she obtained a Bachelor of Science degree in pharmacy from Aston University in Great Britain. She obtained her Ph.D. in pharmacy in 1989 in the Cancer Research Campaign Experimental Chemotherapy Group also at Aston University. She then received a master’s degree in business administration in 1998 from the London School of Business. In 2012, Sue received an honorary doctorate from Aston University.

Mahony joined Lilly in 2000 after more than a decade in sales and marketing roles in the United Kingdom and Europe in oncology/hematology and cardiovascular medicine for Schering-Plough, Amgen and Bristol-Myers Squibb. Since joining Lilly, Mahony has held roles in global marketing, product development, Six Sigma and general management, including global brand development leader for duloxetine (Cymbalta®) and fluoxetine (Prozac®).

In 2010, Mahony was recognized as one of the Indianapolis Business Journal’s “Women of Influence.” Mahony has served on the board of the United Way of Central Indiana since 2010. Sue joined the Board of Directors of Park Tudor School in 2015.

Sue and her husband, John, have two children: Thomas and Rebecca.

Stephen Ubl

Stephen Ubl

President & CEO, PhRMA

Read more

Stephen Ubl is president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA), which represents America's leading biopharmaceutical research companies. Mr. Ubl leads PhRMA's work preserving and strengthening a health care and economic environment that encourages medical innovation, new drug discovery, and access to life-saving medicines. If anyone can find areas of agreement with the critics, or at least work productively with them, it may be Mr. Ubl," the New York Times' Robert Pear wrote in February 2016. "He is more conversant with the intricacies of health policy, and more adept at the politics." He is routinely recognized as one of Washington’s most effective advocates, and, in 2017, was named for the second year in a row to Modern Healthcare’s “100 Most Influential People in Healthcare.” In 2016, he was named a Top Lobbyist by The Hill and a top health influencer by Medical Marketing & Media and PR Week magazines.

Bharat Tewarie

Bharat Tewarie

Executive Vice President, Chief Marketing Officer, UCB

Read more

Bharat Tewarie joins UCB with 27 years of experience in the pharma and biotech industry. He has acquired impressive worldwide expertise while leading global business unit teams to great success. His past experience in domains such as immunology and neurology are a great match to UCB’s core focus areas. His knowledge of markets around the world is also key to helping UCB prepare for future product launches. Trained as a medical doctor (MD), Bharat Tewarie also has an extensive background in multiple aspects of pharmaceutical management, including P&L responsibility, business development, sales, global marketing, clinical research and medical affairs. He has dedicated his career to better understanding patients living with chronic diseases and how to best meet their needs. At UCB Bharat heads the Global Strategic Marketing Practice and is a member of the Executive Committee.

Markus Leyck Dieken

Markus Leyck Dieken

SVP, Global Head CNS, TEVA

Read more

More information coming soon...

Session Speakers

Cheryl MacDiarmid

Cheryl MacDiarmid

Senior Vice President, Primary Care, US, GSK

Read more

More information coming soon...

David Blair

David Blair

Head of Industry, Healthcare, Google

Read more

David Blair is Head of Industry for Health at Google. He leads a team that provides thought leadership, digital marketing strategies, insights, and cross-platform advertising solutions utilizing Google’s search, content network, YouTube, mobile, programmatic and analytics platforms for the world’s leading pharmaceutical and consumer health companies. Prior to Google, David was General Manager/SVP of Provider Solutions at Everyday Health.

David began his digital career in 1997 at iVillage as Vice President of Strategic Sponsorships where he pioneered many of the first digital marketing initiatives with Fortune 500 companies including P&G, Coke, Ford, Kimberly Clark, Kellogg’s and Fuji Film. He moved into the digital health space in 2001 as SVP/Group Publisher for Johnson & Johnson’s BabyCenter.com and was SVP of Ad Sales for Revolution Health, before the merger with Everyday Health in 2008.

Blair serves on the Google Healthcare Advisory Board, was named one of the top 40 Healthcare Transformers in the US by Medical Marketing & Media in 2015 and was a juror for the 2016 Clio Health Awards. He is a frequent keynote speaker at major agencies and industry events, most recently the IMCAS World Congress; Cannes Lions Health, American Heart Association, and Cleveland Clinic’s Patient Experience Summit.

Jason DeGoes

Jason DeGoes

Senior Vice President, Global Patient Solutions, TEVA

Read more

More information coming soon...

Tolga Tanguler

Tolga Tanguler

President, North America, Rare Diseases, Pfizer

Read more

Tolga Tanguler is the Regional President, North America for Rare Diseases at Pfizer. In this role, Tolga leads an organization of more than 200 colleagues across marketing, sales, access, medical and corporate affairs and a portfolio of 6 assets to ensure they are focused on one objective: to transform patients’ lives. A key focus is to ensure that the engagement and experience of rare disease patients and their families are at the forefront of all programs; while ensuring the organization is prepared for the next phase of scientific breakthroughs, including gene therapy.

Tolga has more than 15 years of experience in the global pharmaceutical industry, including leadership roles in both developed markets such as the US, Japan and the Nordics and emerging economies including Africa/Middle East and Latin America. Most recently, Tolga was the Vice President, Global Marketing for ELIQUIS. Throughout these various assignments, the organizations led by Tolga were recognized for their rapid growth performance, as well as their strong culture that led to a significant improvement in colleague engagement. 

Tolga has Bachelor of Science degrees in Economics & Finance from University of Istanbul, and a Masters of Business Administration in Marketing and Supply Chain from Michigan State University. He also has a Post Graduate Degree in Marketing from the University of California. Tolga was recently appointed as a member of the Board of Directors of the National Association of Specialty Pharmacy.

Bozidar Joviecevic MD/MBA

Bozidar Joviecevic MD/MBA

Global Head of Digital Medicines, Sanofi

Read more

More information coming soon...

Celeste Warren

Celeste Warren

Vice President, Human Resources and Global Diversity and Inclusion Center of Excellence, Merck

Read more

More information coming soon...

Wendy Mayer

Wendy Mayer

Vice President Strategy, Pfizer Innovation Health

Read more

Wendy Mayer is Vice President of Strategy, Pfizer Innovative Health, responsible for advising and tracking the development and execution of the business strategy for Pfizer’s innovative business.

Since joining Pfizer in 1997 Wendy has had various roles across the organization including VP of Worldwide Innovation, Connecticut State Director for Primary Care, VP Clinical Trial Excellence, and leadership of various Market Analytics teams across the organization. Wendy currently leads Pfizer’s New York Women’s Leadership Network.

Prior to Pfizer, Wendy was a Senior Consultant at Deloitte & Touche Consulting and did an administrative fellowship at Northwestern Memorial Hospital in Chicago. Wendy holds a bachelor’s degree and MBA from Cornell University. She has been identified by Deloitte as a “Women to Watch” in healthcare, she is on the board of advisors at Pulse@MassChallenge digital health accelerator, and is a board member for AWIS (Association for Women in Science).

Alexis Normand

Alexis Normand

Head of B2B, Nokia Health

Read more

More information coming soon...

Molly Painter

Molly Painter

VP, Sales, Shire

Read more

More information coming soon...

Andrea Heslin Smiley

Andrea Heslin Smiley

President and Chief Executive Officer, VMS BioMarketing

Read more

Andrea Heslin Smiley serves as President and Chief Executive Officer of VMS BioMarketing, a patient support solutions company utilizing nurse educators to improve patient adherence and outcomes.

Ms. Smiley joined VMS BioMarketing in July 2008 to lead the company’s strategic marketing and brand development business groups, and was named President and CEO in 2011. Prior to VMS, Ms. Smiley was an executive at Eli Lilly and Company where she worked for 12 years in strategic business development roles as well as increasingly senior leadership positions in the diabetes, growth hormone, and osteoporosis business units. She has launched multiple biotech and pharmaceutical drugs and devices in injection-naïve markets, negotiated product labels with the FDA, led the development of Eli Lilly and Company’s first Risk Management Plan, repositioned late-stage products that resulted in increased market share growth, and developed and implemented customer-focused sales models. She began her career with Harvard University as a business development analyst and was a management consultant with Putnam Associates, a Boston-area firm focused on companies in the pharmaceutical, biotechnology, and diagnostics businesses. Ms. Smiley serves on numerous boards including the Egalet Corporation and several prominent charitable organizations, and she received a gubernatorial appointment to the Indiana Commission for Women. She earned her BA in economics from DePauw University where she was an Honors Management Fellow, and is a graduate of the Harvard Business School executive education program.

Andre Cote

André Côté

VP / COO - Chief Operating Officer, Commercial Capabilities and Customer Experience, Eli Lilly Canada

Read more

Mr. André Côté holds the position of VP & Chief Operating Officer - Commercial Capabilities and Customer Experience for Eli Lilly Canada Inc. In this role, he is responsible for enhancing the company’s customer facing capabilities, and improving the experience the organization provides for patients, healthcare professionals and payers. Mr. Côté is also a member of the Senior Management Team of Eli Lilly Canada.

Since joining Eli Lilly Canada in 1993 as a Sales Representative, Mr. Côté has held a number of progressive roles in Canada within the Sales, Operations, Learning and Development, and Corporate Affairs organizations, including Government and Economic Affairs Manager, Sales & Operations Director for Quebec, as well as Vice President of Sales.

Mr. Côté has also held various Global leadership positions at Lilly in Pricing, Reimbursement & Access, as well as Global Brand Marketing Strategy. He was also a member of the Senior Leadership Teams for Global Corporate Affairs, and the Global BioMedicines Business Unit. Most recently, Mr. Côté held the position of Senior Director, Global Customer Support Programs at Lilly Corporate Center in Indianapolis, overseeing corporate strategy and capabilities development within the organization.

Prior to joining Eli Lilly Canada, Mr. Côté obtained a Bachelor’s Degree in Business and Marketing in 1993 from the Université Laval in Quebec.

Mr. Côté is fluent in both English and French.

Nicole Mowad-Nassar

Nicole Mowad-Nassar

Vice President & Head of U.S. Business Operations & External Partnerships, Takeda Pharmaceuticals

Read more

More information coming soon...

Jim O’Donoghue

Jim O’Donoghue

VP, S3 Connected Health

Read more

Jim O’Donoghue is head of S3 Connected Health.  He has 30 years’ experience in designing and delivering innovative services and solutions across healthcare, consumer and communications sectors.

Over the past 12 years Jim and his team have designed digital patient support solutions for Pharma and Healthcare Providers that are available across 40 countries, including the largest telehealth program in the UK, and the largest chronic disease management program in Europe.

Jim serves a on the industry steering committee for the Applied Research Centre for Connected Health and served on the industry board for the UK “3 Million Lives” program.

Lisa Deschamps

Lisa Deschamps

WW Head Neuroscience, Novartis

Read more

More information coming soon...

Beyhan Zaim

Beyhan Zaim

Global Head, Alzheimer's Disease Franchise, Eisai, Inc.

Read more

More information coming soon...

Andrew Schorr

Andrew Schorr

Founder, Patient Power

Read more

Andrew Schorr, co-founder of PatientPower.info, is a medical journalist and pioneer in online education of patients with chronic conditions and cancer. Since 1996 he has been a cancer patient himself, living with chronic lymphocytic leukemia and myelofibrosis. He has participated in two clinical trials and is an outspoken advocate for patients worldwide having access to state-of-the-art testing, treatments and clinical trials. Andrew’s company, Patient Power LLC, now reaches more than 140,000 cancer patients and family members each month. Often their efforts connect patients directly with pharma leaders to promote understanding and collaboration. Andrew is the author of the acclaimed book. “The Web-Savvy Patient”. He holds journalism degrees from the University of North Carolina and Columbia University.

Elena Cant

Elena Cant

Vice President, Head of Global Commercial, Vaccine Business Unit, Takeda Pharmaceuticals

Read more

More information coming soon...

Meredith Hardy

Meredith Hardy

Patient Advocate

Read more

More information coming soon...

Peter Barschdorff

Peter Barschdorff

Vice President, Business Insights, Bayer

Read more

More information coming soon...

Michael Suesserman

Michael Suesserman

Vice President, Marketing, Regeneron

Read more

Mike joined Regeneron in 2015 as Vice President, Marketing, overseeing both the in-line products as well as those in development. Over the past year Mike oversaw the launch of both Kevzara® (sarilumab) for rheumatoid arthritis and Dupixent® (dupilumab) for atopic dermatitis. Mike was instrumental in Regeneron’s move to a business unit model and now runs both the Ophthalmology and Cardio-metabolic Commercial Business Units.

Mike spent the bulk of his biopharma career at Pfizer in roles of increasing responsibility. He led the US and Global Marketing Teams for Pfizer’s blockbuster brand, Lipitor (atorvastatin) and oversaw the Global marketing of Viagra® (sildenafil citrate) while leading the Global Urology/Sexual Health Franchise. Mike was also Vice President of the Managed Care Business Unit.

After Pfizer, Mike focused on more entrepreneurial ventures. In 2011 he joined HarkHealth, a privately funded IT start-up as President, taking a “back of the envelope” concept to an in-market offering. In 2013, Mike joined Cello Health as Managing Director, Early Product Commercialization, working with companies to ensure the products they are developing will achieve commercial success.

Mike has Board of Directors experience, having served from 2014 to 2016 on the Board of Directors of Repros Therapeutics Inc., a NASDAQ listed development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health.

Mike holds a BA from Clark University and an MBA from Kelley School of Business.

Jay Graves

Jay Graves

Vice President, Sales, Roche Diabetes Care, Inc.

Read more

More information coming soon...

Tricia Brown

Tricia Brown

Executive Director, Leader of US Promotion Organization, Merck

Read more

More information coming soon...

Terri Young

Terri Young

Worldwide General Manager, Cardiology, Bristol-Myers Squibb

Read more

More information coming soon...

Abhimanyu Verma

Abhimanyu Verma

Global Head - Applied Technology Innovation, Novartis

Read more

More information coming soon...

Jerry Berger

Jerry Berger

Senior Manager, Healthcare, Samsung

Read more

Jerry Berger possesses over 20 years of IT marketing within the healthcare space. He is currently the Senior Manager for Marketing for Samsung Healthcare where he markets mobility and wearable solutions to hospitals, long-term care, pharmas and consumer health organizations. Prior to his current tenure at Samsung, he worked for Siemens Healthcare and marketed healthcare analytics and value-added services to the acute hospital space. Jerry possesses an MBA from The American University in Washington DC.

David O’Reilly

David O’Reilly

Chief Platform Officer, Proteus Digital Health

Read more

More information coming soon...

Andrew Wright

Andrew Wright

VP Digital Medicine, Otsuka America Pharmaceutical, Inc.

Read more

More information coming soon...

Deb Hussain

Deb Hussain

Senior Director of Marketing, MCE Team Leader, Lilly

Read more

More information coming soon...

Paul Gileno

Paul Gileno

Founder/President, US Pain Foundation inc.

Read more

More information coming soon...

Paul Lazzaro

Paul Lazzaro

Vice President, US Primary Care Sales & Key Accounts, Horizon Pharma plc

Read more

More information coming soon...

Danielle Salowski

Danielle Salowski

Industry Manager, Facebook Health

Read more

Danielle Salowski leads the Health Industry Vertical at Facebook, where her team is focused on defining go-to-market strategies for advertising and innovation in the Health space. Facebook Health’s mission is to connect people to the information or services they need to improve lives and create better health outcomes. Prior to joining Facebook, Danielle spent 11 years in the Digital and Social Media space across various roles at Twitter, CafeMom and News Corp. Danielle graduated from Villanova University with a degree in Communication.

Andrew Ploszay

Andrew Ploszay

Head, Digital Innovation & Strategic Partnerships, GSK

Read more

More information coming soon...

Steve Morin

Steve Morin

Health Programs Coordinator, Office of Health & Constituent Affairs, FDA

Read more

More information coming soon...

Georgia Krehbiel

Georgia Krehbiel

National Director of Development, Adult Congenital Heart Association

Read more

More information coming soon...

All Speakers

Jim Robinson

Jim Robinson

President US, Astellas

Read more

More information coming soon...

Fabrice Chouraqui

Fabrice Chouraqui

President US, Novartis

Read more

Fabrice Chouraqui is currently working as President of Novartis Pharmaceuticals Corporation.

Fabrice has 20 years of experience in the Pharmaceutical industry, having worked in Research & Development, Commercial and General Management positions in Europe, North America, Asia and Latin America. Prior to joining Novartis in 2010, Fabrice worked for Bristol-Myers Squibb and Hoechst Marion Roussel.

Fabrice holds a Master in Science and a Doctorate in Pharmacy from the University of Paris as well as an MBA degree from INSEAD.

Paul Navarre

Paul Navarre

CEO, Ferring Holding

Read more

Paul Navarre is the Chief Executive Officer of Ferring Holding Inc., the U.S. subsidiary of Ferring Pharmaceuticals (The Ferring Group). Ferring Holding Inc. has more than 800 employees and turnover of over $700M.

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. Ferring identifies, develops and markets innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology, women’s health and orthopaedics.

An accomplished senior executive, Mr. Navarre has built a track record of success spanning 25 years including experience in fast-moving consumer goods and pharmaceuticals. He has served in key strategic positions responsible for operations in Europe, Asia, Africa, Middle East and the U.S. A French national, he has lived and worked in France, Italy, the UK, Switzerland and the U.S.A.

Before joining Ferring, Mr. Navarre was President of International Operations for Allergan. He began his career at Procter and Gamble where over 15 years he held multiple leadership positions in the company’s consumer goods and pharmaceuticals divisions.

Mr. Navarre has solid track record of delivering top line growth in the specialty pharmaceutical business through commercial innovation and customer centric approaches. He is recognized as an authentic visionary leader with the ability to attract and manage multi-functional talents.

Mr. Navarre and his wife have been married for 23 years. They have 4 children and live in New York.

Dr. Carsten Brunn

Dr. Carsten Brunn

Head of Pharmaceuticals, Americas Region, Bayer

Read more

Dr. Brunn was appointed in January 2017 to lead Bayer’s Pharmaceuticals business in the United States, Canada, and Latin America and is an executive member of the Country Council.

Over the last 25 years, he has held a number of senior leadership positions in Europe, Asia and the United States at leading companies such as Eli Lilly, Novartis and Bausch and Lomb. Most recently, he was Head of Bayer Pharmaceuticals Commercial Operations in Japan where he achieved double-digit growth that led to Bayer being recognized as one of the top 10 pharmaceutical companies in Japan for the first time in 26 years. He also served as the Chairman of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan, an organization representing 24 R&D based innovative pharmaceutical companies in Japan. Dr. Brunn joined Bayer Pharmaceuticals in China in 2011 to lead the Global Primary Care business.

Dr. Brunn started his career at Eli Lilly and Company, where he held a variety of managerial positions in sales and marketing in the United States. He is passionate about meeting the needs of customers and patients and has a proven track record for building the right internal culture to drive business growth.

Dr. Brunn graduated from the University of Freiburg in Germany with a Master of Science in Pharmaceutical Science. In addition, he studied at the University of Washington under a research scholarship. He received his PhD in Chemistry from the University of Hamburg, Germany and completed his executive education at London Business School.

Born in Tuebingen, Germany, Dr. Carsten Brunn is married with one son and resides in New Jersey.

Sue Mahony

Sue Mahony

SVP & President, Lilly Oncology

Read more

Sue Mahony, Ph.D., became president of Lilly Oncology in March 2011. She is also a senior vice president for Eli Lilly and Company and a member of the company’s executive committee.

In May 2009, she was appointed senior vice president, human resources and diversity for Lilly. Previously, she led Lilly’s operations in Canada.

Mahony was born and educated in the United Kingdom, where she obtained a Bachelor of Science degree in pharmacy from Aston University in Great Britain. She obtained her Ph.D. in pharmacy in 1989 in the Cancer Research Campaign Experimental Chemotherapy Group also at Aston University. She then received a master’s degree in business administration in 1998 from the London School of Business. In 2012, Sue received an honorary doctorate from Aston University.

Mahony joined Lilly in 2000 after more than a decade in sales and marketing roles in the United Kingdom and Europe in oncology/hematology and cardiovascular medicine for Schering-Plough, Amgen and Bristol-Myers Squibb. Since joining Lilly, Mahony has held roles in global marketing, product development, Six Sigma and general management, including global brand development leader for duloxetine (Cymbalta®) and fluoxetine (Prozac®).

In 2010, Mahony was recognized as one of the Indianapolis Business Journal’s “Women of Influence.” Mahony has served on the board of the United Way of Central Indiana since 2010. Sue joined the Board of Directors of Park Tudor School in 2015.

Sue and her husband, John, have two children: Thomas and Rebecca.

Stephen Ubl

Stephen Ubl

President & CEO, PhRMA

Read more

Stephen Ubl is president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA), which represents America's leading biopharmaceutical research companies. Mr. Ubl leads PhRMA's work preserving and strengthening a health care and economic environment that encourages medical innovation, new drug discovery, and access to life-saving medicines. If anyone can find areas of agreement with the critics, or at least work productively with them, it may be Mr. Ubl," the New York Times' Robert Pear wrote in February 2016. "He is more conversant with the intricacies of health policy, and more adept at the politics." He is routinely recognized as one of Washington’s most effective advocates, and, in 2017, was named for the second year in a row to Modern Healthcare’s “100 Most Influential People in Healthcare.” In 2016, he was named a Top Lobbyist by The Hill and a top health influencer by Medical Marketing & Media and PR Week magazines.

Bharat Tewarie

Bharat Tewarie

Executive Vice President, Chief Marketing Officer, UCB

Read more

Bharat Tewarie joins UCB with 27 years of experience in the pharma and biotech industry. He has acquired impressive worldwide expertise while leading global business unit teams to great success. His past experience in domains such as immunology and neurology are a great match to UCB’s core focus areas. His knowledge of markets around the world is also key to helping UCB prepare for future product launches. Trained as a medical doctor (MD), Bharat Tewarie also has an extensive background in multiple aspects of pharmaceutical management, including P&L responsibility, business development, sales, global marketing, clinical research and medical affairs. He has dedicated his career to better understanding patients living with chronic diseases and how to best meet their needs. At UCB Bharat heads the Global Strategic Marketing Practice and is a member of the Executive Committee.

Markus Leyck Dieken

Markus Leyck Dieken

SVP, Global Head CNS, TEVA

Read more

More information coming soon...

Cheryl MacDiarmid

Cheryl MacDiarmid

Senior Vice President, Primary Care, US, GSK

Read more

More information coming soon...

David Blair

David Blair

Head of Industry, Healthcare, Google

Read more

David Blair is Head of Industry for Health at Google. He leads a team that provides thought leadership, digital marketing strategies, insights, and cross-platform advertising solutions utilizing Google’s search, content network, YouTube, mobile, programmatic and analytics platforms for the world’s leading pharmaceutical and consumer health companies. Prior to Google, David was General Manager/SVP of Provider Solutions at Everyday Health.

David began his digital career in 1997 at iVillage as Vice President of Strategic Sponsorships where he pioneered many of the first digital marketing initiatives with Fortune 500 companies including P&G, Coke, Ford, Kimberly Clark, Kellogg’s and Fuji Film. He moved into the digital health space in 2001 as SVP/Group Publisher for Johnson & Johnson’s BabyCenter.com and was SVP of Ad Sales for Revolution Health, before the merger with Everyday Health in 2008.

Blair serves on the Google Healthcare Advisory Board, was named one of the top 40 Healthcare Transformers in the US by Medical Marketing & Media in 2015 and was a juror for the 2016 Clio Health Awards. He is a frequent keynote speaker at major agencies and industry events, most recently the IMCAS World Congress; Cannes Lions Health, American Heart Association, and Cleveland Clinic’s Patient Experience Summit.

Jason DeGoes

Jason DeGoes

Senior Vice President, Global Patient Solutions, TEVA

Read more

More information coming soon...

Tolga Tanguler

Tolga Tanguler

President, North America, Rare Diseases, Pfizer

Read more

Tolga Tanguler is the Regional President, North America for Rare Diseases at Pfizer. In this role, Tolga leads an organization of more than 200 colleagues across marketing, sales, access, medical and corporate affairs and a portfolio of 6 assets to ensure they are focused on one objective: to transform patients’ lives. A key focus is to ensure that the engagement and experience of rare disease patients and their families are at the forefront of all programs; while ensuring the organization is prepared for the next phase of scientific breakthroughs, including gene therapy.

Tolga has more than 15 years of experience in the global pharmaceutical industry, including leadership roles in both developed markets such as the US, Japan and the Nordics and emerging economies including Africa/Middle East and Latin America. Most recently, Tolga was the Vice President, Global Marketing for ELIQUIS. Throughout these various assignments, the organizations led by Tolga were recognized for their rapid growth performance, as well as their strong culture that led to a significant improvement in colleague engagement. 

Tolga has Bachelor of Science degrees in Economics & Finance from University of Istanbul, and a Masters of Business Administration in Marketing and Supply Chain from Michigan State University. He also has a Post Graduate Degree in Marketing from the University of California. Tolga was recently appointed as a member of the Board of Directors of the National Association of Specialty Pharmacy.

Bozidar Joviecevic MD/MBA

Bozidar Joviecevic MD/MBA

Global Head of Digital Medicines, Sanofi

Read more

More information coming soon...

Celeste Warren

Celeste Warren

Vice President, Human Resources and Global Diversity and Inclusion Center of Excellence, Merck

Read more

More information coming soon...

Wendy Mayer

Wendy Mayer

Vice President Strategy, Pfizer Innovation Health

Read more

Wendy Mayer is Vice President of Strategy, Pfizer Innovative Health, responsible for advising and tracking the development and execution of the business strategy for Pfizer’s innovative business.

Since joining Pfizer in 1997 Wendy has had various roles across the organization including VP of Worldwide Innovation, Connecticut State Director for Primary Care, VP Clinical Trial Excellence, and leadership of various Market Analytics teams across the organization. Wendy currently leads Pfizer’s New York Women’s Leadership Network.

Prior to Pfizer, Wendy was a Senior Consultant at Deloitte & Touche Consulting and did an administrative fellowship at Northwestern Memorial Hospital in Chicago. Wendy holds a bachelor’s degree and MBA from Cornell University. She has been identified by Deloitte as a “Women to Watch” in healthcare, she is on the board of advisors at Pulse@MassChallenge digital health accelerator, and is a board member for AWIS (Association for Women in Science).

Alexis Normand

Alexis Normand

Head of B2B, Nokia Health

Read more

More information coming soon...

Molly Painter

Molly Painter

VP, Sales, Shire

Read more

More information coming soon...

Andrea Heslin Smiley

Andrea Heslin Smiley

President and Chief Executive Officer, VMS BioMarketing

Read more

Andrea Heslin Smiley serves as President and Chief Executive Officer of VMS BioMarketing, a patient support solutions company utilizing nurse educators to improve patient adherence and outcomes.

Ms. Smiley joined VMS BioMarketing in July 2008 to lead the company’s strategic marketing and brand development business groups, and was named President and CEO in 2011. Prior to VMS, Ms. Smiley was an executive at Eli Lilly and Company where she worked for 12 years in strategic business development roles as well as increasingly senior leadership positions in the diabetes, growth hormone, and osteoporosis business units. She has launched multiple biotech and pharmaceutical drugs and devices in injection-naïve markets, negotiated product labels with the FDA, led the development of Eli Lilly and Company’s first Risk Management Plan, repositioned late-stage products that resulted in increased market share growth, and developed and implemented customer-focused sales models. She began her career with Harvard University as a business development analyst and was a management consultant with Putnam Associates, a Boston-area firm focused on companies in the pharmaceutical, biotechnology, and diagnostics businesses. Ms. Smiley serves on numerous boards including the Egalet Corporation and several prominent charitable organizations, and she received a gubernatorial appointment to the Indiana Commission for Women. She earned her BA in economics from DePauw University where she was an Honors Management Fellow, and is a graduate of the Harvard Business School executive education program.

Andre Cote

André Côté

VP / COO - Chief Operating Officer, Commercial Capabilities and Customer Experience, Eli Lilly Canada

Read more

Mr. André Côté holds the position of VP & Chief Operating Officer - Commercial Capabilities and Customer Experience for Eli Lilly Canada Inc. In this role, he is responsible for enhancing the company’s customer facing capabilities, and improving the experience the organization provides for patients, healthcare professionals and payers. Mr. Côté is also a member of the Senior Management Team of Eli Lilly Canada.

Since joining Eli Lilly Canada in 1993 as a Sales Representative, Mr. Côté has held a number of progressive roles in Canada within the Sales, Operations, Learning and Development, and Corporate Affairs organizations, including Government and Economic Affairs Manager, Sales & Operations Director for Quebec, as well as Vice President of Sales.

Mr. Côté has also held various Global leadership positions at Lilly in Pricing, Reimbursement & Access, as well as Global Brand Marketing Strategy. He was also a member of the Senior Leadership Teams for Global Corporate Affairs, and the Global BioMedicines Business Unit. Most recently, Mr. Côté held the position of Senior Director, Global Customer Support Programs at Lilly Corporate Center in Indianapolis, overseeing corporate strategy and capabilities development within the organization.

Prior to joining Eli Lilly Canada, Mr. Côté obtained a Bachelor’s Degree in Business and Marketing in 1993 from the Université Laval in Quebec.

Mr. Côté is fluent in both English and French.

Nicole Mowad-Nassar

Nicole Mowad-Nassar

Vice President & Head of U.S. Business Operations & External Partnerships, Takeda Pharmaceuticals

Read more

More information coming soon...

Jim O’Donoghue

Jim O’Donoghue

VP, S3 Connected Health

Read more

Jim O’Donoghue is head of S3 Connected Health.  He has 30 years’ experience in designing and delivering innovative services and solutions across healthcare, consumer and communications sectors.

Over the past 12 years Jim and his team have designed digital patient support solutions for Pharma and Healthcare Providers that are available across 40 countries, including the largest telehealth program in the UK, and the largest chronic disease management program in Europe.

Jim serves a on the industry steering committee for the Applied Research Centre for Connected Health and served on the industry board for the UK “3 Million Lives” program.

Lisa Deschamps

Lisa Deschamps

WW Head Neuroscience, Novartis

Read more

More information coming soon...

Beyhan Zaim

Beyhan Zaim

Global Head, Alzheimer's Disease Franchise, Eisai, Inc.

Read more

More information coming soon...

Andrew Schorr

Andrew Schorr

Founder, Patient Power

Read more

Andrew Schorr, co-founder of PatientPower.info, is a medical journalist and pioneer in online education of patients with chronic conditions and cancer. Since 1996 he has been a cancer patient himself, living with chronic lymphocytic leukemia and myelofibrosis. He has participated in two clinical trials and is an outspoken advocate for patients worldwide having access to state-of-the-art testing, treatments and clinical trials. Andrew’s company, Patient Power LLC, now reaches more than 140,000 cancer patients and family members each month. Often their efforts connect patients directly with pharma leaders to promote understanding and collaboration. Andrew is the author of the acclaimed book. “The Web-Savvy Patient”. He holds journalism degrees from the University of North Carolina and Columbia University.

Elena Cant

Elena Cant

Vice President, Head of Global Commercial, Vaccine Business Unit, Takeda Pharmaceuticals

Read more

More information coming soon...

Meredith Hardy

Meredith Hardy

Patient Advocate

Read more

More information coming soon...

Peter Barschdorff

Peter Barschdorff

Vice President, Business Insights, Bayer

Read more

More information coming soon...

Michael Suesserman

Michael Suesserman

Vice President, Marketing, Regeneron

Read more

Mike joined Regeneron in 2015 as Vice President, Marketing, overseeing both the in-line products as well as those in development. Over the past year Mike oversaw the launch of both Kevzara® (sarilumab) for rheumatoid arthritis and Dupixent® (dupilumab) for atopic dermatitis. Mike was instrumental in Regeneron’s move to a business unit model and now runs both the Ophthalmology and Cardio-metabolic Commercial Business Units.

Mike spent the bulk of his biopharma career at Pfizer in roles of increasing responsibility. He led the US and Global Marketing Teams for Pfizer’s blockbuster brand, Lipitor (atorvastatin) and oversaw the Global marketing of Viagra® (sildenafil citrate) while leading the Global Urology/Sexual Health Franchise. Mike was also Vice President of the Managed Care Business Unit.

After Pfizer, Mike focused on more entrepreneurial ventures. In 2011 he joined HarkHealth, a privately funded IT start-up as President, taking a “back of the envelope” concept to an in-market offering. In 2013, Mike joined Cello Health as Managing Director, Early Product Commercialization, working with companies to ensure the products they are developing will achieve commercial success.

Mike has Board of Directors experience, having served from 2014 to 2016 on the Board of Directors of Repros Therapeutics Inc., a NASDAQ listed development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health.

Mike holds a BA from Clark University and an MBA from Kelley School of Business.

Jay Graves

Jay Graves

Vice President, Sales, Roche Diabetes Care, Inc.

Read more

More information coming soon...

Tricia Brown

Tricia Brown

Executive Director, Leader of US Promotion Organization, Merck

Read more

More information coming soon...

Terri Young

Terri Young

Worldwide General Manager, Cardiology, Bristol-Myers Squibb

Read more

More information coming soon...

Abhimanyu Verma

Abhimanyu Verma

Global Head - Applied Technology Innovation, Novartis

Read more

More information coming soon...

Jerry Berger

Jerry Berger

Senior Manager, Healthcare, Samsung

Read more

Jerry Berger possesses over 20 years of IT marketing within the healthcare space. He is currently the Senior Manager for Marketing for Samsung Healthcare where he markets mobility and wearable solutions to hospitals, long-term care, pharmas and consumer health organizations. Prior to his current tenure at Samsung, he worked for Siemens Healthcare and marketed healthcare analytics and value-added services to the acute hospital space. Jerry possesses an MBA from The American University in Washington DC.

David O’Reilly

David O’Reilly

Chief Platform Officer, Proteus Digital Health

Read more

More information coming soon...

Andrew Wright

Andrew Wright

VP Digital Medicine, Otsuka America Pharmaceutical, Inc.

Read more

More information coming soon...

Deb Hussain

Deb Hussain

Senior Director of Marketing, MCE Team Leader, Lilly

Read more

More information coming soon...

Paul Gileno

Paul Gileno

Founder/President, US Pain Foundation inc.

Read more

More information coming soon...

Paul Lazzaro

Paul Lazzaro

Vice President, US Primary Care Sales & Key Accounts, Horizon Pharma plc

Read more

More information coming soon...

Danielle Salowski

Danielle Salowski

Industry Manager, Facebook Health

Read more

Danielle Salowski leads the Health Industry Vertical at Facebook, where her team is focused on defining go-to-market strategies for advertising and innovation in the Health space. Facebook Health’s mission is to connect people to the information or services they need to improve lives and create better health outcomes. Prior to joining Facebook, Danielle spent 11 years in the Digital and Social Media space across various roles at Twitter, CafeMom and News Corp. Danielle graduated from Villanova University with a degree in Communication.

Andrew Ploszay

Andrew Ploszay

Head, Digital Innovation & Strategic Partnerships, GSK

Read more

More information coming soon...

Steve Morin

Steve Morin

Health Programs Coordinator, Office of Health & Constituent Affairs, FDA

Read more

More information coming soon...

Georgia Krehbiel

Georgia Krehbiel

National Director of Development, Adult Congenital Heart Association

Read more

More information coming soon...

Don't miss out - register now

Only 2 days left to save $400 with our Just Launched discount. Don't miss out!